Gilead Sciences sets aside $200 million to resolve HIV drug probe
Gilead Sciences set aside $200 million for a potential settlement with federal prosecutors to resolve an investigation into ...
Our progress in ending the HIV/AIDS epidemic shows the importance of federal support
We can now prevent HIV transmissions and deaths — progress impossible without investments from the U.S. government ...
FiercePharma1d
How studying innovative HIV medicines in the “real world” helps HCPs and patients make the best decisions for treatment and prevention
| Dr. Buzón discusses bridging science and reality, highlighting the vital role of real-world evidence in advancing HIV care ...
EurekAlert!1d
New HIV vaccine candidate discovered with help from Argonne’s Advanced Photon Source
Protein crystallization at the SER-CAT beamline at Argonne’s Advanced Photon Source proved key to the discovery of a new HIV vaccine candidate.
"A whole new level of cruelty": Health experts decry "devastating" cuts to HIV treatment programs
The Elizabeth Glaser Pediatric AIDS Foundation said the latest cuts will deprive 350,000 people of HIV treatment.
Rolling Out5d
HIV breakthrough faces critical funding cuts
A revolutionary advancement in HIV prevention technology stands at a critical crossroads as recent policy decisions threaten ...
MadameNoire6d
HIV Myth-Busters: Debunking The Biggest Misconceptions In Black Communities
MadameNoire breaks down three common myths about HIV that persist today. Together, let's uncover the truth behind the stigma.
FiercePharma12h
Gilead sets aside $200M for potential settlement over HIV drug speaker program
Weeks after settling a five-year patent dispute with the U.S. | Gilead set aside approximately $200 million for a potential ...
HIV cases on the rise in Penobscot County
According to the Maine CDC, all 21 of the recent cases have been linked to injection drug use, and 90 percent of those ...
'HIV in soda' hoax scares Philippine social media users
HIV cannot be transmitted through drinking "contaminated" soda, health experts said, refuting hoax posts that frightened ...
Hosted on MSN8h
The Global Fund will roll out the twice-yearly anti-HIV jab — with or without Pepfar
The major backer of the lenacapavir roll-out is assuring nervous researchers that they will keep their part of funding ...